Marinomed Biotech AG | WebDisclosure

PRESS RELEASE

published on 09/24/2024 at 07:45, 1 year 10 months ago

Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops
Marinomed Biotech AG reports positive clinical results for Carragelose eye drops, improving dry eye symptoms by 54%. The eye drops are well tolerated and hold valid Medical Device Directive certificate

Marinomed Biotech AG Carragelose Clinical Results Dry Eye Eye Drops
BRIEF

published on 09/18/2024 at 17:26, 1 year 10 months ago

Marinomed Biotech AG Announces Capital Increase Excluding Subscription Rights

Investors Capital Increase Marinomed Biotech AG Subscription Rights Issue Price
BRIEF

published on 09/18/2024 at 17:26, 1 year 10 months ago

Marinomed Biotech AG annonce une augmentation de capital hors droits de souscription

Augmentation De Capital Investisseurs Marinomed Biotech AG Droits De Souscription Prix D'émission
PRESS RELEASE

published on 09/18/2024 at 17:21, 1 year 10 months ago

EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Marinomed Biotech AG resolves capital increase by issuing 154,053 bearer shares at EUR 5 per share, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Subscription Rights Bearer Shares EUR 5
BRIEF

published on 09/15/2024 at 17:54, 1 year 10 months ago

Marinomed Biotech AG Sets Price Range for Capital Increases

Capital Increase Restructuring Share Price Investor Negotiations Marinomed Biotech
BRIEF

published on 09/15/2024 at 17:54, 1 year 10 months ago

Marinomed Biotech AG fixe une fourchette de prix pour ses augmentations de capital

Augmentation De Capital Restructuration Cours De L'action Biotechnologie Marinomed Négociations Avec Les Investisseurs
PRESS RELEASE

published on 09/15/2024 at 17:49, 1 year 10 months ago

EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights
Marinomed Biotech AG sets price range for potential 10% capital increase and second capital increase, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Price Range Authorized Capital 2024 Restructuring Proceedings
BRIEF

published on 09/11/2024 at 07:50, 1 year 10 months ago

Marinomed Biotech AG: First Carragelose Products Receive New Medical Device Regulation (MDR) Certification

Regulatory Compliance Medical Devices Carragelose MDR Certification Marinomed
BRIEF

published on 09/11/2024 at 07:50, 1 year 10 months ago

Marinomed Biotech AG : les premiers produits à base de carraghénane reçoivent la nouvelle certification du Règlement sur les dispositifs médicaux (MDR)

Dispositifs Médicaux Conformité Réglementaire Certification MDR Marinomé Carraghénose
PRESS RELEASE

published on 09/11/2024 at 07:45, 1 year 10 months ago

Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification
Marinomed Biotech AG's first Carragelose products receive new Medical Device Regulation (MDR) certification, enhancing safety and value for the portfolio

Regulatory Compliance Medical Devices Marinomed Biotech AG MDR Certification Carragelose Products

Published on 08/07/2026 at 00:45, 11 hours 34 minutes ago

NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 13 hours 4 minutes ago

LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 14 hours 4 minutes ago

Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 14 hours 14 minutes ago

Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 14 hours 19 minutes ago

Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE

View all ACCESSWIRE

Published on 08/07/2026 at 12:05, 13 minutes ago

Genel Energy PLC: Response to announcement made by DNO ASA
Published on 08/07/2026 at 11:12, 1 hour 7 minutes ago

EQS-Adhoc: Asklepios Kliniken GmbH & Co. KGaA submits request for the implementation of a squeeze-out of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft
Published on 08/07/2026 at 11:00, 1 hour 19 minutes ago

MuniFin Group’s Half Year Report January–June 2026 is published
Published on 08/07/2026 at 11:00, 1 hour 19 minutes ago

PWO Group generates new business of EUR 363m and increases free cash flow in the first half of 2026
Published on 08/07/2026 at 10:45, 1 hour 34 minutes ago

Coolita launches Indonesia's first FAST Media Alliance with leading broadcasters

View all EQS

Published on 08/07/2026 at 08:30, 3 hours 49 minutes ago

Disclosure of shares outstanding and voting rights - 07.08.2026
Published on 08/07/2026 at 08:30, 3 hours 49 minutes ago

Déclaration nombre d'actions et droits de vote - 07.08.2026
Published on 08/06/2026 at 18:26, 17 hours 53 minutes ago

Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 18:26, 17 hours 53 minutes ago

Air Liquide droits de vote au 31 juillet 2026
Published on 08/06/2026 at 17:46, 18 hours 33 minutes ago

Déclaration des droits de vote à fin juillet 2026

View all LES ECHOS COMFI WIRE

News